Page last updated: 2024-11-06

perylenediimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Perylenediimides (PDIs) are a class of organic dyes known for their exceptional photostability, high fluorescence quantum yields, and strong electron-accepting properties. They are commonly synthesized through a multi-step process involving the condensation of perylene dianhydride with primary amines. PDIs exhibit a wide range of applications, including organic electronics, sensors, and bioimaging. Their strong electron-accepting nature makes them suitable for use in organic solar cells and organic field-effect transistors. Their high fluorescence quantum yields and photostability enable their use as fluorescent probes and dyes in biological imaging and sensing. The unique electronic and optical properties of PDIs have driven extensive research into their synthesis, modification, and applications.'

perylenediimide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

perylenediimide : The 3,4,9,10-tetracarboxylic diimide derivative of perylene. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID66475
CHEBI ID52753
SCHEMBL ID29541
MeSH IDM0511692

Synonyms (48)

Synonym
AC-19761
nsc16842
anthra[2,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2h,9h)-tetrone
3,9,10-perylenetetracarboxylic 3,4:9,10-diimide
3,9,10-perylenetetracarboxylic acid diimide
perylimid
81-33-4
nsc-16842
STK805783
isoquino[4',5',6':6,5,10]anthra[2,1,9-def]isoquinoline-1,3,8,10(2h,9h)-tetrone
AKOS000518175
perylene-3,4:9,10-tetracarboxydiimide
3,4,9,10-perylenetetracarboxylic acid diimide
CHEBI:52753
perylenediimide
anthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2h,9h)-tetrone
P0984
3,4,9,10-perylenetetracarboxylic diimide
63nli8842l ,
ec 201-344-6
3,4,9,10-perylenetetracarboxylic 3,4:9,10-diimide
unii-63nli8842l
nsc 16842
einecs 201-344-6
FT-0614183
c.i. 71129
anthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline- 1,3,8,10(2h,9h)-tetrone
ci 71129
anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2h,9h)-tetrone
SCHEMBL29541
anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2h,9h)-tetraone
W-109285
anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10-tetraone
euvinyl maroon 478
lumogen black fk 4281
paliogen red violet fm
irgazin violet 129
mfcd00024144
DTXSID9052555
AS-14506
Q16948010
7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone
3,4,9,10-perylene- tetracarboxylic diimide
YSWG760
CS-0010188
3,4,9,10-perylenetetracarboxylic-diimide
SY020052
HY-D0285
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic heteropolycyclic compound
dicarboximideAn imide in which the two acyl substituents on nitrogen are carboacyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (179)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (8.94)29.6817
2010's136 (75.98)24.3611
2020's27 (15.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.77 (24.57)
Research Supply Index5.19 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index56.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (2.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other175 (97.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]